Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism

Authors:
  • ICIsabel Caraballo
    Isabel Caraballo
  • FFFernando Rodriguez de Fonseca
    Fernando Rodriguez de Fonseca
  • FBFadwa El Banoua
    Fadwa El Banoua
  • BFBelen Ferrer
    Belen Ferrer
  • JFJuan A. Flores
    Juan A. Flores
  • BGBeatriz Galan-Rodriguez
    Beatriz Galan-Rodriguez

Abstract
No abstract available

This publication has 42 references indexed in Scilit: